210 related articles for article (PubMed ID: 28190159)
1. A systematic review of the impact of pain on overall survival in patients with cancer.
Zylla D; Steele G; Gupta P
Support Care Cancer; 2017 May; 25(5):1687-1698. PubMed ID: 28190159
[TBL] [Abstract][Full Text] [Related]
2. Is regular systemic opioid analgesia associated with shorter survival in adult patients with cancer? A systematic literature review.
Boland JW; Ziegler L; Boland EG; McDermid K; Bennett MI
Pain; 2015 Nov; 156(11):2152-2163. PubMed ID: 26207652
[TBL] [Abstract][Full Text] [Related]
3. Quality of life data as prognostic indicators of survival in cancer patients: an overview of the literature from 1982 to 2008.
Montazeri A
Health Qual Life Outcomes; 2009 Dec; 7():102. PubMed ID: 20030832
[TBL] [Abstract][Full Text] [Related]
4. The impact of pain and opioids use on survival in cancer patients: Results from a population-based cohort study and a meta-analysis.
Zheng J; He J; Wang W; Zhou H; Cai S; Zhu L; Qian X; Wang J; Lu Z; Huang C
Medicine (Baltimore); 2020 Feb; 99(9):e19306. PubMed ID: 32118751
[TBL] [Abstract][Full Text] [Related]
5. Impact of opioid use on health care utilization and survival in patients with newly diagnosed stage IV malignancies.
Zylla D; Steele G; Shapiro A; Richter S; Gupta P
Support Care Cancer; 2018 Jul; 26(7):2259-2266. PubMed ID: 29396593
[TBL] [Abstract][Full Text] [Related]
6. Use of opioid analgesics or sleeping medication and survival of cancer patients.
Chang WP; Lin CC
Eur J Oncol Nurs; 2015 Jun; 19(3):199-206. PubMed ID: 25553718
[TBL] [Abstract][Full Text] [Related]
7. Opioid prescribing for cancer pain during the last 3 months of life: associated factors and 9-year trends in a nationwide United Kingdom cohort study.
Higginson IJ; Gao W
J Clin Oncol; 2012 Dec; 30(35):4373-9. PubMed ID: 23109701
[TBL] [Abstract][Full Text] [Related]
8. S-phase fraction determined on fine needle aspirates is an independent prognostic factor in breast cancer - a multivariate study of 770 patients.
Gazic B; Pizem J; Bracko M; Cufer T; Borstnar S; Pohar-Marinsek Z; Us-Krasovec M
Cytopathology; 2008 Oct; 19(5):294-302. PubMed ID: 18070112
[TBL] [Abstract][Full Text] [Related]
9. Pain intensity as prognostic factor in cancer pain management.
Mercadante S; Porzio G; Adile C; Aielli F; Cortegiani A; Caruselli A; Casuccio A
Pain Pract; 2015 Jan; 15(1):E1-8. PubMed ID: 25387823
[TBL] [Abstract][Full Text] [Related]
10. A global analysis of multitrial data investigating quality of life and symptoms as prognostic factors for survival in different tumor sites.
Quinten C; Martinelli F; Coens C; Sprangers MA; Ringash J; Gotay C; Bjordal K; Greimel E; Reeve BB; Maringwa J; Ediebah DE; Zikos E; King MT; Osoba D; Taphoorn MJ; Flechtner H; Schmucker-Von Koch J; Weis J; Bottomley A;
Cancer; 2014 Jan; 120(2):302-11. PubMed ID: 24127333
[TBL] [Abstract][Full Text] [Related]
11. Baseline quality of life as a prognostic indicator of survival: a meta-analysis of individual patient data from EORTC clinical trials.
Quinten C; Coens C; Mauer M; Comte S; Sprangers MA; Cleeland C; Osoba D; Bjordal K; Bottomley A;
Lancet Oncol; 2009 Sep; 10(9):865-71. PubMed ID: 19695956
[TBL] [Abstract][Full Text] [Related]
12. Pain, opioid use, and survival in hospitalized patients with advanced cancer.
Brescia FJ; Portenoy RK; Ryan M; Krasnoff L; Gray G
J Clin Oncol; 1992 Jan; 10(1):149-55. PubMed ID: 1345797
[TBL] [Abstract][Full Text] [Related]
13. Spinal cord stimulation for cancer-related pain in adults.
Lihua P; Su M; Zejun Z; Ke W; Bennett MI
Cochrane Database Syst Rev; 2013 Feb; (2):CD009389. PubMed ID: 23450600
[TBL] [Abstract][Full Text] [Related]
14. Opioid switching in patients with advanced cancer followed at home. A retrospective analysis.
Mercadante S; Valle A; Porzio G; Fusco F; Aielli F; Adile C; Casuccio A;
J Pain Symptom Manage; 2013 Feb; 45(2):298-304. PubMed ID: 23102561
[TBL] [Abstract][Full Text] [Related]
15. Association of the Charlson comorbidity index and hypertension with survival in men with metastatic castration-resistant prostate cancer.
Goyal J; Pond GR; Galsky MD; Hendricks R; Small A; Tsao CK; Sonpavde G
Urol Oncol; 2014 Jan; 32(1):36.e27-34. PubMed ID: 23685020
[TBL] [Abstract][Full Text] [Related]
16. NSAIDS or paracetamol, alone or combined with opioids, for cancer pain.
McNicol E; Strassels SA; Goudas L; Lau J; Carr DB
Cochrane Database Syst Rev; 2005 Jan; (1):CD005180. PubMed ID: 15654708
[TBL] [Abstract][Full Text] [Related]
17. Severe pericardial effusion in patients with concurrent malignancy: a retrospective analysis of prognostic factors influencing survival.
Dequanter D; Lothaire P; Berghmans T; Sculier JP
Ann Surg Oncol; 2008 Nov; 15(11):3268-71. PubMed ID: 18648881
[TBL] [Abstract][Full Text] [Related]
18. Prevalence and predictors of cognitive dysfunction in opioid-treated patients with cancer: a multinational study.
Kurita GP; Sjøgren P; Ekholm O; Kaasa S; Loge JH; Poviloniene I; Klepstad P
J Clin Oncol; 2011 Apr; 29(10):1297-303. PubMed ID: 21357785
[TBL] [Abstract][Full Text] [Related]
19. Factors influencing opioid-taking self-efficacy and analgesic adherence in Taiwanese outpatients with cancer.
Liang SY; Yates P; Edwards H; Tsay SL
Psychooncology; 2008 Nov; 17(11):1100-7. PubMed ID: 18314911
[TBL] [Abstract][Full Text] [Related]
20. Prognostic values of EORTC QLQ-C30 and QLQ-HCC18 index-scores in patients with hepatocellular carcinoma - clinical application of health-related quality-of-life data.
Li L; Mo FK; Chan SL; Hui EP; Tang NS; Koh J; Leung LK; Poon AN; Hui J; Chu CM; Lee KF; Ma BB; Lai PB; Chan AT; Yu SC; Yeo W
BMC Cancer; 2017 Jan; 17(1):8. PubMed ID: 28052758
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
